Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Ross Baldessarini

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Living Beings

Chemicals & Drugs

Concepts & Ideas

Anatomy

Corpus Striatum

Phenomena

Recurrence

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
54
Kula, Nora
48
Tondo, Leonardo
45
Tarazi, Frank
39
Neumeyer, John
32
Hennen, John
26
Campbell, A
25
Zhang, Kehong
24
Tohen, Mauricio
22
Salvatore, Paola
18
Centorrino, Franca
16
Viguera, Adele
15
Baethge, Christopher
12
Teicher, Martin
11
Baldwin, Ronald
11
Tamagnan, Gilles

Sign-in to see all Coauthors

Publications

TOP 3
Vieta E; Berk M; Wang W; Colom F; Tohen M; Baldessarini R J
Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients.
Fawcett Jan A; Baldessarini Ross J; Coryell William H; Silverman Morton M; Stein Dan J
Definition and management of suicidality in psychiatric patients.
Baethge Christopher; Tondo Leonardo; Lepri Beatrice; Baldessarini Ross J
Coffee and cigarette use: association with suicidal acts in 352 Sardinian bipolar disorder patients.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Ross Baldessarini (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Vieta E; Berk M; Wang W; Colom F; Tohen M; Baldessarini R J
Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients.
Journal of affective disorders 2009;119(1-3):22-7.
2009: Fawcett Jan A; Baldessarini Ross J; Coryell William H; Silverman Morton M; Stein Dan J
Definition and management of suicidality in psychiatric patients.
The Journal of clinical psychiatry 2009;70(10):e38.
2009: Baethge Christopher; Tondo Leonardo; Lepri Beatrice; Baldessarini Ross J
Coffee and cigarette use: association with suicidal acts in 352 Sardinian bipolar disorder patients.
Bipolar disorders 2009;11(5):494-503.
2009: Fawcett Jan A; Baldessarini Ross J; Coryell William H; Silverman Morton M; Stein Dan J
Defining and managing suicidal risk in patients taking psychotropic medications.
The Journal of clinical psychiatry 2009;70(6):782-9.
2009: Baldessarini Ross J
Atypical antipsychotic drugs and the risk of sudden cardiac death.
The New England journal of medicine 2009;360(20):2136-7; author reply 2137-8.
2009: Girardi Paolo; Pompili Maurizio; Innamorati Marco; Mancini Michele; Serafini Gianluca; Mazzarini Lorenzo; Del Casale Antonio; Tatarelli Roberto; Baldessarini Ross J
Duloxetine in acute major depression: review of comparisons to placebo and standard antidepressants using dissimilar methods.
Human psychopharmacology 2009;24(3):177-90.
2009: Salvatore Paola; Baldessarini Ross J; Tohen Mauricio; Khalsa Hari-Mandir K; Sanchez-Toledo Jesus Perez; Zarate Carlos A; Vieta Eduard; Maggini Carlo
McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients.
The Journal of clinical psychiatry 2009;70(4):458-66.
2009: Baldessarini R J; Tondo L
Suicidal risks during treatment of bipolar disorder patients with lithium versus anticonvulsants.
Pharmacopsychiatry 2009;42(2):72-5.
2009: Wingo Aliza P; Harvey Philip D; Baldessarini Ross J
Neurocognitive impairment in bipolar disorder patients: functional implications.
Bipolar disorders 2009;11(2):113-25.
2009: Si Yu-Gui; Choi Yong-Kee; Gardner Matthew P; Tarazi Frank I; Baldessarini Ross J; Neumeyer John L
Synthesis and neuropharmacological evaluation of esters of R(-)-N-alkyl-11-hydroxy-2-methoxynoraporphines.
Bioorganic & medicinal chemistry letters 2009;19(1):51-3.
2009: Gross Anne; Altman Matthew; Salvatore Paola; Baldessarini Ross J; Chanoff Marni; Powers Joseph P
An atypical, chronic psychotic disorder in a 55-year-old man.
Harvard review of psychiatry 2009;17(5):329-43.
2009: Vigo Daniel V; Baldessarini Ross J
Anticonvulsants in the treatment of major depressive disorder: an overview.
Harvard review of psychiatry 2009;17(4):231-41.
2009: Trede Katharina; Baldessarini Ross J; Viguera Adele C; Bottero Alain
Treatise on insanity in pregnant, postpartum, and lactating women (1858) by Louis-Victor Marcé: a commentary.
Harvard review of psychiatry 2009;17(2):157-65.
2008: Baldessarini Ross J
Comments on article by Dr Birkenhager et al: "Efficacy of imipramine in psychotic versus nonpsychotic depression".
Journal of clinical psychopharmacology 2008;28(6):716; author reply 717-8.
2008: Baldessarini Ross; Henk Henry; Sklar Ami; Chang Jane; Leahy Leslie
Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence.
Psychiatric services (Washington, D.C.) 2008;59(10):1175-83.
2008: Baethge Christopher; Hennen John; Khalsa Hari-Mandir Kaur; Salvatore Paola; Tohen Mauricio; Baldessarini Ross J
Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients.
Bipolar disorders 2008;10(6):738-41.
2008: Talamo Alessandra; Baldessarini Ross J; Centorrino Franca
Comparison of mania patients suitable for treatment trials versus clinical treatment.
Human psychopharmacology 2008;23(6):447-54.
2008: Tondo L; Lepri B; Baldessarini R J
Suicidal status during antidepressant treatment in 789 Sardinian patients with major affective disorder.
Acta psychiatrica Scandinavica 2008;118(2):106-15.
2008: Tsapakis Evangelia M; Soldani Federico; Tondo Leonardo; Baldessarini Ross J
Efficacy of antidepressants in juvenile depression: meta-analysis.
The British journal of psychiatry : the journal of mental science 2008;193(1):10-7.
2008: Si Yu-Gui; Gardner Matthew P; Tarazi Frank I; Baldessarini Ross J; Neumeyer John L
Synthesis and binding studies of 2-O- and 11-O-substituted N-alkylnoraporphines.
Bioorganic & medicinal chemistry letters 2008;18(14):3971-3.
2008: Newport D Jeffrey; Stowe Zachary N; Viguera Adele C; Calamaras Martha R; Juric Sandra; Knight Bettina; Pennell Page B; Baldessarini Ross J
Lamotrigine in bipolar disorder: efficacy during pregnancy.
Bipolar disorders 2008;10(3):432-6.
2008: Salvatore Paola; Ghidini Stefano; Zita Gianmaria; De Panfilis Chiara; Lambertino Samuele; Maggini Carlo; Baldessarini Ross J
Circadian activity rhythm abnormalities in ill and recovered bipolar I disorder patients.
Bipolar disorders 2008;10(2):256-65.
2008: Baldessarini Ross J; Perry Richard; Pike James
Factors associated with treatment nonadherence among US bipolar disorder patients.
Human psychopharmacology 2008;23(2):95-105.
2008: Si Yu-Gui; Gardner Matthew P; Tarazi Frank I; Baldessarini Ross J; Neumeyer John L
Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selectivity.
Journal of medicinal chemistry 2008;51(4):983-7.
2008: Baldessarini Ross J; Tondo Leonardo
Lithium and suicidal risk.
Bipolar disorders 2008;10(1):114-5.
2008: Khalsa Hari Mandir Kaur; Salvatore Paola; Hennen John; Baethge Christopher; Tohen Mauricio; Baldessarini Ross J
Suicidal events and accidents in 216 first-episode bipolar I disorder patients: predictive factors.
Journal of affective disorders 2008;106(1-2):179-84.
2008: Bois Frederic; Baldwin Ronald M; Amici Louis; Al-Tikriti Mohammed S; Kula Nora; Baldessarini Ross; Innis Robert B; Staley Julie K; Tamagnan Gilles D
Synthesis, radiolabeling and baboon SPECT imaging of 2beta-carbomethoxy-3beta-(3'-[(123)I]iodophenyl)tropane ([(123)I]YP256) as a serotonin transporter radiotracer.
Nuclear medicine and biology 2008;35(1):53-9.
2008: Centorrino Franca; Cincotta Stephanie L; Talamo Alessandra; Fogarty Kate V; Guzzetta Francesca; Saadeh Mark G; Salvatore Paola; Baldessarini Ross J
Hospital use of antipsychotic drugs: polytherapy.
Comprehensive psychiatry 2008;49(1):65-9.
2008: Frankenburg Frances R; Baldessarini Ross J
Neurosyphilis, malaria, and the discovery of antipsychotic agents.
Harvard review of psychiatry 2008;16(5):299-307.
2008: Salvatore Paola; Bhuvaneswar Chaya; Ebert Daniel; Maggini Carlo; Baldessarini Ross J
Cycloid psychoses revisited: case reports, literature review, and commentary.
Harvard review of psychiatry 2008;16(3):167-80.
2008: Nykiel Sherry A; Baldessarini Ross J; Bower Montgomery C; Goodwin Jean; Salvatore Paola
Psychosis NOS: search for diagnostic clarity.
Harvard review of psychiatry 2008;16(1):55-65.
2007: Viguera Adele C; Whitfield Theodore; Baldessarini Ross J; Newport D Jeffrey; Stowe Zachary; Reminick Alison; Zurick Amanda; Cohen Lee S
Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation.
The American journal of psychiatry 2007;164(12):1817-24; quiz 1923.
2007: Tondo L; Lepri B; Baldessarini R J
Suicidal risks among 2826 Sardinian major affective disorder patients.
Acta psychiatrica Scandinavica 2007;116(6):419-28.
2007: Salvatore P; Khalsa H M K; Hennen J; Tohen M; Yurgelun-Todd D; Casolari F; Depanfilis C; Maggini C; Baldessarini R J
Psychopathology factors in first-episode affective and non-affective psychotic disorders.
Journal of psychiatric research 2007;41(9):724-36.
2007: Valuck Robert J; Libby Anne M; Orton Heather D; Morrato Elaine H; Allen Richard; Baldessarini Ross J
Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs.
The American journal of psychiatry 2007;164(8):1198-205.
2007: Kyomen Helen H; Whitfield Theodore H; Baldessarini Ross J
Levetiracetam for manic behavior in hospitalized geriatric patients with dementia of the Alzheimer's type.
Journal of clinical psychopharmacology 2007;27(4):408-10.
2007: Si Yu-Gui; Gardner Matthew P; Tarazi Frank I; Baldessarini Ross J; Neumeyer John L
R-(-)-N-alkyl-11-hydroxy-10-hydroxymethyl- and 10-methyl-aporphines as 5-HT1A receptor ligands.
Bioorganic & medicinal chemistry letters 2007;17(15):4128-30.
2007: Baldessarini Ross J; Tondo Leonardo; Strombom Indiana M; Dominguez Svetlana; Fawcett Jan; Licinio Julio; Oquendo Maria A; Tollefson Gary D; Valuck Robert J; Tohen Mauricio
Ecological studies of antidepressant treatment and suicidal risks.
Harvard review of psychiatry 2007;15(4):133-45.
2007: Baldessarini Ross J; Tondo Leonardo; Baethge Christopher J; Lepri Beatrice; Bratti Irene M
Effects of treatment latency on response to maintenance treatment in manic-depressive disorders.
Bipolar disorders 2007;9(4):386-93.
2007: Moran-Gates Taylor; Grady Christopher; Shik Park Young; Baldessarini Ross J; Tarazi Frank I
Effects of risperidone on dopamine receptor subtypes in developing rat brain.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2007;17(6-7):448-55.
2007: Salvatore Paola; Tohen Mauricio; Khalsa Hari-Mandir Kaur; Baethge Christopher; Tondo Leonardo; Baldessarini Ross J
Longitudinal research on bipolar disorders.
Epidemiologia e psichiatria sociale 2007;16(2):109-17.
2007: Sim Kang; Lee N B; Chua Hong C; Mahendran Rathi; Fujii Senta; Yang Shu-Yu; Chong Mian-Yoon; Si Tianmei; He Yan L; Lee Min S; Sung Kil M; Chung Eun K; Chan Yiong H; Shinfuku Naotaka; Tan Chay H; Sartorius Norman; Baldessarini Ross J
Newer antidepressant drug use in East Asian psychiatric treatment settings: REAP (Research on East Asia Psychotropic Prescriptions) Study.
British journal of clinical pharmacology 2007;63(4):431-7.
2007: Guzzetta Francesca; Tondo Leonardo; Centorrino Franca; Baldessarini Ross J
Lithium treatment reduces suicide risk in recurrent major depressive disorder.
The Journal of clinical psychiatry 2007;68(3):380-3.
2007: Pantazopoulos Harry; Lange Nicholas; Baldessarini Ross J; Berretta Sabina
Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia.
Biological psychiatry 2007;61(5):640-52.
2007: Huxley Nancy; Baldessarini Ross J
Disability and its treatment in bipolar disorder patients.
Bipolar disorders 2007;9(1-2):183-96.
2007: Viguera Adele C; Newport D Jeffrey; Ritchie James; Stowe Zachary; Whitfield Theodore; Mogielnicki Juliana; Baldessarini Ross J; Zurick Amanda; Cohen Lee S
Lithium in breast milk and nursing infants: clinical implications.
The American journal of psychiatry 2007;164(2):342-5.
2007: Zhang Ao; Zhang Yi; Branfman Alan R; Baldessarini Ross J; Neumeyer John L
Advances in development of dopaminergic aporphinoids.
Journal of medicinal chemistry 2007;50(2):171-81.
2007: Baldessarini Ross J; Leahy Leslie; Arcona Stephen; Gause Douglas; Zhang Winnie; Hennen John
Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders.
Psychiatric services (Washington, D.C.) 2007;58(1):85-91.
2007: Zhang Ao; Neumeyer John L; Baldessarini Ross J
Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders.
Chemical reviews 2007;107(1):274-302.
2007: Tamagnan Gilles D; Brenner Eric; Alagille David; Staley Julie K; Haile Colin; Koren Andrei; Early Michelle; Baldwin Ronald M; Tarazi Frank I; Baldessarini Ross J; Jarkas Nachwa; Goodman Mark M; Seibyl John P
Development of SPECT imaging agents for the norepinephrine transporters: [123I]INER.
Bioorganic & medicinal chemistry letters 2007;17(2):533-7.
2007: Viguera Adele Casals; Koukopoulos Alexia; Muzina David J; Baldessarini Ross J
Teratogenicity and anticonvulsants: lessons from neurology to psychiatry.
The Journal of clinical psychiatry 2007;68 Suppl 9():29-33.
2007: Ghaemi S Nassir; Baldessarini Ross J
The manic-depressive spectrum and mood stabilization: Kraepelin's ghost.
Psychotherapy and psychosomatics 2007;76(2):65-9.
2006: Acharya Nayan; Rosen Amy S; Polzer John P; D'Souza Deborah N; Perahia David G; Cavazzoni Patrizia A; Baldessarini Ross J
Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder.
Journal of clinical psychopharmacology 2006;26(6):587-94.
2006: Baldessarini Ross J; Tondo Leonardo; Davis Paula; Pompili Maurizio; Goodwin Frederick K; Hennen John
Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review.
Bipolar disorders 2006;8(5 Pt 2):625-39.
2006: Gonzalez-Pinto Ana; Mosquera Fernando; Alonso Marta; López Purificación; Ramírez Fernando; Vieta Eduard; Baldessarini Ross J
Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment.
Bipolar disorders 2006;8(5 Pt 2):618-24.
2006: Bois Frederic; Baldwin Ronald M; Kula Nora S; Baldessarini Ross J; Al Tikriti M; Innis Robert B; Tamagnan Gilles D
Synthesis and monoamine transporter affinity of 2beta-carbomethoxy-3beta-(4'-p-substituted phenyl)-piperidine analogs of cocaine.
Bioorganic & medicinal chemistry letters 2006;16(19):5222-5.
2006: Talamo A; Centorrino F; Tondo L; Dimitri A; Hennen J; Baldessarini R J
Comorbid substance-use in schizophrenia: relation to positive and negative symptoms.
Schizophrenia research 2006;86(1-3):251-5.
2006: Houston John P; Ahl Jonna; Meyers Adam L; Kaiser Christopher J; Tohen Mauricio; Baldessarini Ross J
Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex.
The Journal of clinical psychiatry 2006;67(8):1246-52.
2006: Baldessarini Ross J; Pompili Maurizio; Tondo Leonardo
Suicide in bipolar disorder: Risks and management.
CNS spectrums 2006;11(6):465-71.
2006: Minnai Gian Paolo; Tondo Leonardo; Salis Piergiorgio; Ghiani Carmen; Manfredi Andrea; Paluello Michela M; Baethge Christopher; Baldessarini Ross J
Secular trends in first hospitalizations for major mood disorders with comorbid substance use.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2006;9(3):319-26.
2006: Tarsy Daniel; Baldessarini Ross J
Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?
Movement disorders : official journal of the Movement Disorder Society 2006;21(5):589-98.
2006: Tondo Leonardo; Albert Matthew J; Baldessarini Ross J
Suicide rates in relation to health care access in the United States: an ecological study.
The Journal of clinical psychiatry 2006;67(4):517-23.
2006: Centorrino Franca; Hennen John; Mallya Gopinath; Egli Samy; Clark Tim; Baldessarini Ross J
Clinical outcome in patients with bipolar I disorder, obsessive compulsive disorder or both.
Human psychopharmacology 2006;21(3):189-93.
2006: Tondo Leonardo; Baldessarini Ross J
Strategies to prevent suicide.
JAMA : the journal of the American Medical Association 2006;295(13):1515; author reply 1516.
2006: Baldessarini Ross J; Pompili Maurizio; Tondo Leonardo
Suicidal risk in antidepressant drug trials.
Archives of general psychiatry 2006;63(3):246-8.
2006: Mann J John; Emslie Graham; Baldessarini Ross J; Beardslee William; Fawcett Jan A; Goodwin Frederick K; Leon Andrew C; Meltzer Herbert Y; Ryan Neal D; Shaffer David; Wagner Karen D
ACNP Task Force report on SSRIs and suicidal behavior in youth.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(3):473-92.
2006: Tóth Miklós; Berényi Sándor; Csutorás Csaba; Kula Nora S; Zhang Kehong; Baldessarini Ross J; Neumeyer John L
Synthesis and dopamine receptor binding of sulfur-containing aporphines.
Bioorganic & medicinal chemistry 2006;14(6):1918-23.
2006: Moran-Gates Taylor; Gan Lu; Park Young Shik; Zhang Kehong; Baldessarini Ross J; Tarazi Frank I
Repeated antipsychotic drug exposure in developing rats: dopamine receptor effects.
Synapse (New York, N.Y.) 2006;59(2):92-100.
2006: Tamagnan Gilles; Alagille David; Fu Xing; Kula Nora S; Baldessarini Ross J; Innis Robert B; Baldwin Ronald M
Synthesis and monoamine transporter affinity of new 2beta-carbomethoxy-3beta-[aryl or heteroaryl]phenyltropanes.
Bioorganic & medicinal chemistry letters 2006;16(1):217-20.
2005: Grant Marni J; Baldessarini Ross J
Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole.
The Annals of pharmacotherapy 2005;39(11):1953.
2005: Centorrino Franca; Fogarty Kate V; Sani Gabriele; Salvatore Paola; Cincotta Stephanie L; Hennen John; Guzzetta Francesca; Talamo Alessandra; Saadeh Mark G; Baldessarini Ross J
Use of combinations of antipsychotics: McLean Hospital inpatients, 2002.
Human psychopharmacology 2005;20(7):485-92.
2005: Derenne Jennifer L; Baldessarini Ross J
Clozapine toxicity associated with smoking cessation: case report.
American journal of therapeutics 2005;12(5):469-71.
2005: Moran-Gates Taylor; Zhang Kehong; Baldessarini Ross J; Tarazi Frank I
Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(3):439-44.
2005: Lasser Robert A; Bossie Cynthia A; Gharabawi Georges M; Baldessarini Ross J
Clinical improvement in 336 stable chronically psychotic patients changed from oral to long-acting risperidone: a 12-month open trial.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(3):427-38.
2005: Centorrino Franca; Fogarty Kate V; Cimbolli Paola; Salvatore Paola; Thompson Terri-Ann; Sani Gabriele; Cincotta Stephanie L; Baldessarini Ross J
Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients.
Journal of psychiatric practice 2005;11(4):241-7.
2005: Centorrino Franca; Fogarty Kate V; Sani Gabriele; Salvatore Paola; Cimbolli Paola; Baldessarini Ross J
Antipsychotic drug use: McLean Hospital, 2002.
Human psychopharmacology 2005;20(5):355-8.
2005: Soldani F; Ghaemi S N; Baldessarini R J
Research reports on treatments for bipolar disorder: preliminary assessment of methodological quality.
Acta psychiatrica Scandinavica 2005;112(1):72-4.
2005: Soldani Federico; Ghaemi S Nassir; Baldessarini Ross
Research methods in psychiatric treatment studies. Critique and proposals.
Acta psychiatrica Scandinavica 2005;112(1):1-3.
2005: Gardner David M; Baldessarini Ross J; Waraich Paul
Modern antipsychotic drugs: a critical overview.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2005;172(13):1703-11.
2005: Trede Katharina; Salvatore Paola; Baethge Christopher; Gerhard Angela; Maggini Carlo; Baldessarini Ross J
Manic-depressive illness: evolution in Kraepelin's Textbook, 1883-1926.
Harvard review of psychiatry 2005;13(3):155-78.
2005: Baethge Christopher; Baldessarini Ross J; Khalsa Hari-Mandir Kaur; Hennen John; Salvatore Paola; Tohen Mauricio
Substance abuse in first-episode bipolar I disorder: indications for early intervention.
The American journal of psychiatry 2005;162(5):1008-10.
2005: Baethge Christopher; Baldessarini Ross J; Freudenthal Klaus; Streeruwitz Anna; Bauer Michael; Bschor Tom
Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia.
Bipolar disorders 2005;7(2):136-45.
2005: Baldessarini Ross J; Faedda Gianni L; Hennen John
Risk of mania with antidepressants.
Archives of pediatrics & adolescent medicine 2005;159(3):298; author reply 298-9.
2005: Hennen John; Baldessarini Ross J
Suicidal risk during treatment with clozapine: a meta-analysis.
Schizophrenia research 2005;73(2-3):139-45.
2005: Zhu Meng-Yang; Wang Wei-Ping; Baldessarini Ross J; Kim Kwang-Soo
Effects of desipramine treatment on tyrosine hydroxylase gene expression in cultured neuroblastoma cells and rat brain tissue.
Brain research. Molecular brain research 2005;133(2):167-75.
2005: Baethge Christopher; Baldessarini Ross J; Mathiske-Schmidt Kirsten; Hennen John; Berghöfer Anne; Müller-Oerlinghausen Bruno; Bschor Tom; Adli Mazda; Bauer Michael
Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients.
The Journal of clinical psychiatry 2005;66(2):174-82.
2005: Tamagnan Gilles; Alagille David; Fu Xing; Kula Nora S; Baldessarini Ross J; Innis Robert B; Baldwin Ronald M
Synthesis and monoamine transporter affinity of new 2beta-carbomethoxy-3beta-[4-(substituted thiophenyl)]phenyltropanes: discovery of a selective SERT antagonist with picomolar potency.
Bioorganic & medicinal chemistry letters 2005;15(4):1131-3.
2005: Chengappa K N Roy; Hennen John; Baldessarini Ross J; Kupfer David J; Yatham Lakshmi N; Gershon Samuel; Baker Robert W; Tohen Mauricio
Recovery and functional outcomes following olanzapine treatment for bipolar I mania.
Bipolar disorders 2005;7(1):68-76.
2004: Hennen John; Perlis Roy H; Sachs Gary; Tohen Mauricio; Baldessarini Ross J
Weight gain during treatment of bipolar I patients with olanzapine.
The Journal of clinical psychiatry 2004;65(12):1679-87.
2004: Centorrino Franca; MacLean Elizabeth; Salvatore Paola; Kidwell Jennifer E; Fogarty Kate V; Berry Judith M; Baldessarini Ross J
Ziprasidone: first year experience in a hospital setting.
Journal of psychiatric practice 2004;10(6):361-7.
2004: Peng Xuemei; Zhang Ao; Kula Nora S; Baldessarini Ross J; Neumeyer John L
Synthesis and amine transporter affinities of novel phenyltropane derivatives as potential positron emission tomography (PET) imaging agents.
Bioorganic & medicinal chemistry letters 2004;14(22):5635-9.
2004: Vieta Eduard; Calabrese Joseph R; Hennen John; Colom Francesc; Martínez-Arán Anabel; Sánchez-Moreno Jose; Yatham Lakshmi N; Tohen Mauricio; Baldessarini Ross J
Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data.
The Journal of clinical psychiatry 2004;65(10):1420-8.
2004: Faedda Gianni L; Baldessarini Ross J; Glovinsky Ira P; Austin Nancy B
Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review.
Journal of affective disorders 2004;82(1):149-58.
2004: Zhang Kehong; Grady Christopher J; Tsapakis Evangelia M; Andersen Susan L; Tarazi Frank I; Baldessarini Ross J
Regulation of working memory by dopamine D4 receptor in rats.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(9):1648-55.
2004: Tarazi Frank I; Zhang Kehong; Baldessarini Ross J
Dopamine D4 receptors: beyond schizophrenia.
Journal of receptor and signal transduction research 2004;24(3):131-47.
2004: Faedda Gianni L; Baldessarini Ross J; Glovinsky Ira P; Austin Nancy B
Pediatric bipolar disorder: phenomenology and course of illness.
Bipolar disorders 2004;6(4):305-13.
2004: Csutoras Csaba; Zhang Ao; Zhang Kehong; Kula Nora S; Baldessarini Ross J; Neumeyer John L
Synthesis and neuropharmacological evaluation of R(-)-N-alkyl-11-hydroxynoraporphines and their esters.
Bioorganic & medicinal chemistry 2004;12(13):3553-9.
2004: Baethge Christopher; Glovinsky Ira; Baldessarini Ross J
Manic-depressive illness in children: an early twentieth-century view by Theodor Ziehen (1862-1950). Introduction.
History of psychiatry 2004;15(58 Pt 2):201-26.
2004: Bois Frederic; Baldwin Ronald M; Kula Nora S; Baldessarini Ross J; Innis Robert B; Tamagnan Gilles
Synthesis and monoamine transporter affinity of 3'-analogs of 2-beta-carbomethoxy-3-beta-(4'-iodophenyl)tropane (beta-CIT).
Bioorganic & medicinal chemistry letters 2004;14(9):2117-20.
2004: Centorrino Franca; Goren Jessica L; Hennen John; Salvatore Paola; Kelleher James P; Baldessarini Ross J
Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits.
The American journal of psychiatry 2004;161(4):700-6.
2004: Baldessarini Ross J; Hennen John
Genetics of suicide: an overview.
Harvard review of psychiatry 2004;12(1):1-13.
2004: Ghaemi S Nassir; Rosenquist Klara J; Ko James Y; Baldassano Claudia F; Kontos Nicholas J; Baldessarini Ross J
Antidepressant treatment in bipolar versus unipolar depression.
The American journal of psychiatry 2004;161(1):163-5.
2004: Oepen Godehard; Baldessarini Ross J; Salvatore Paola; Slater Eliot
On the periodicity of manic-depressive insanity, by Eliot Slater (1938): translated excerpts and commentary.
Journal of affective disorders 2004;78(1):1-9.
2004: Gan Lu; Falzone Tomas L; Zhang Kehong; Rubinstein Marcelo; Baldessarini Ross J; Tarazi Frank I
Enhanced expression of dopamine D(1) and glutamate NMDA receptors in dopamine D(4) receptor knockout mice.
Journal of molecular neuroscience : MN 2004;22(3):167-78.
2003: Tohen Mauricio; Zarate Carlos A; Hennen John; Khalsa Hari-Mandir Kaur; Strakowski Stephen M; Gebre-Medhin Priscilla; Salvatore Paola; Baldessarini Ross J
The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence.
The American journal of psychiatry 2003;160(12):2099-107.
2003: Beresin Eugene V; Baldessarini Ross J; Alpert Jonathan; Rosenbaum Jerrold
Teaching ethics of psychopharmacology research in psychiatric residency training programs.
Psychopharmacology 2003;171(1):105-11.
2003: Baldwin Ronald M; Fu Xing; Kula Nora S; Baldessarini Ross J; Amici Louis; Innis Robert B; Tamagnan Gilles D
Synthesis and affinity of a possible byproduct of electrophilic radiolabeling of [123I]IBZM.
Bioorganic & medicinal chemistry letters 2003;13(22):4015-7.
2003: Centorrino Franca; Albert Matthew J; Berry Judith M; Kelleher James P; Fellman Veronica; Line Gyorgy; Koukopoulos Alexia E; Kidwell Jennifer E; Fogarty Kate V; Baldessarini Ross J
Oxcarbazepine: clinical experience with hospitalized psychiatric patients.
Bipolar disorders 2003;5(5):370-4.
2003: Meltzer Herbert Y; Baldessarini Ross J
Reducing the risk for suicide in schizophrenia and affective disorders.
The Journal of clinical psychiatry 2003;64(9):1122-9.
2003: Baethge Christopher; Salvatore Paola; Baldessarini Ross J
Cyclothymia, a circular mood disorder.
History of psychiatry 2003;14(55 Pt 3):377-99.
2003: Bratti Irene M; Baldessarini Ross J; Baethge Christopher; Tondo Leonardo
Pretreatment episode count and response to lithium treatment in manic-depressive illness.
Harvard review of psychiatry 2003;11(5):245-56.
2003: Baldessarini Ross J; Tondo Leonardo
Suicide risk and treatments for patients with bipolar disorder.
JAMA : the journal of the American Medical Association 2003;290(11):1517-9.
2003: Tarazi Frank I; Baldessarini Ross J; Kula Nora S; Zhang Kehong
Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: implications for antipsychotic drug treatment.
The Journal of pharmacology and experimental therapeutics 2003;306(3):1145-51.
2003: Baethge Christopher; Tondo Leonardo; Bratti Irene M; Bschor Tom; Bauer Michael; Viguera Adele C; Baldessarini Ross J
Prophylaxis latency and outcome in bipolar disorders.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2003;48(7):449-57.
2003: Neumeyer John L; Kula Nora S; Bergman Jack; Baldessarini Ross J
Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines.
European journal of pharmacology 2003;474(2-3):137-40.
2003: Baldessarini Ross J; Hennen John; Wilson Michael; Calabrese Joseph; Chengappa Roy; Keck Paul E; McElroy Susan L; Sachs Gary; Vieta Eduard; Welge Jeffrey A; Yatham Lakshmi N; Zarate Carlos A; Baker Robert W; Tohen Mauricio
Olanzapine versus placebo in acute mania: treatment responses in subgroups.
Journal of clinical psychopharmacology 2003;23(4):370-6.
2003: Glod Carol A; Lynch Arlene; Flynn Elizabeth; Berkowitz Cynthia; Baldessarini Ross J
Open trial of bupropion SR in adolescent major depression.
Journal of child and adolescent psychiatric nursing : official publication of the Association of Child and Adolescent Psychiatric Nurses, Inc 2003;16(3):123-30.
2003: Centorrino F; Albert M J; Drago-Ferrante G; Koukopoulos A E; Berry J M; Baldessarini R J
Delirium during clozapine treatment: incidence and associated risk factors.
Pharmacopsychiatry 2003;36(4):156-60.
2003: Centorrino Franca; Kelleher James P; Berry Judith M; Salvatore Paola; Eakin Marion; Fogarty Kate V; Fellman Veronica; Baldessarini Ross J
Pilot comparison of extended-release and standard preparations of divalproex sodium in patients with bipolar and schizoaffective disorders.
The American journal of psychiatry 2003;160(7):1348-50.
2003: Tondo L; Hennen J; Baldessarini R J
Rapid-cycling bipolar disorder: effects of long-term treatments.
Acta psychiatrica Scandinavica 2003;108(1):4-14.
2003: Baldessarini Ross J; Tondo Leonardo; Hennen John
Treatment-latency and previous episodes: relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders.
Bipolar disorders 2003;5(3):169-79.
2003: Baldessarini Ross J
Assessment of treatment response in mania: commentary and new findings.
Bipolar disorders 2003;5(2):79-84.
2003: Davids Eugen; Zhang Kehong; Tarazi Frank I; Baldessarini Ross J
Animal models of attention-deficit hyperactivity disorder.
Brain research. Brain research reviews 2003;42(1):1-21.
2003: Joffe Hadine; Hall Janet E; Cohen Lee S; Taylor Ann E; Baldessarini Ross J
A putative relationship between valproic acid and polycystic ovarian syndrome: implications for treatment of women with seizure and bipolar disorders.
Harvard review of psychiatry 2003;11(2):99-108.
2003: Baethge Christopher; Salvatore Paola; Baldessarini Ross J
"On cyclic insanity" by Karl Ludwig Kahlbaum, MD: a translation and commentary.
Harvard review of psychiatry 2003;11(2):78-90.
2003: Frazier Jean A; Cohen Louise Glassner; Jacobsen Leslie; Grothe Dale; Flood James; Baldessarini Ross J; Piscitelli Stephen; Kim Grace S; Rapoport Judith L
Clozapine pharmacokinetics in children and adolescents with childhood-onset schizophrenia.
Journal of clinical psychopharmacology 2003;23(1):87-91.
2003: Tondo Leonardo; Isacsson Göran; Baldessarini Ross
Suicidal behaviour in bipolar disorder: risk and prevention.
CNS drugs 2003;17(7):491-511.
2003: Baldessarini Ross J; Tondo Leonardo; Hennen John
Lithium treatment and suicide risk in major affective disorders: update and new findings.
The Journal of clinical psychiatry 2003;64 Suppl 5():44-52.
2002: Viguera Adele C; Cohen Lee S; Bouffard Suzanne; Whitfield T Hatch; Baldessarini Ross J
Reproductive decisions by women with bipolar disorder after prepregnancy psychiatric consultation.
The American journal of psychiatry 2002;159(12):2102-4.
2002: Tarazi Frank I; Zhang Kehong; Baldessarini Ross J
Long-term effects of newer antipsychotic drugs on neuronal nitric oxide synthase in rat brain.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2002;7(4):297-300.
2002: Centorrino Franca; Eakin Marion; Bahk Won-Myong; Kelleher James P; Goren Jessica; Salvatore Paola; Egli Samy; Baldessarini Ross J
Inpatient antipsychotic drug use in 1998, 1993, and 1989.
The American journal of psychiatry 2002;159(11):1932-5.
2002: Viguera Adele C; Cohen Lee J; Tondo Leonardo; Baldessarini Ross J
Protective effect of pregnancy on the course of lithium-responsive bipolar I disorder.
Journal of affective disorders 2002;72(1):107-8; author reply 103-5.
2002: Salvatore Paola; Baldessarini Ross J; Centorrino Franca; Egli Samy; Albert Matthew; Gerhard Angela; Maggini Carlo
Weygandt's On the Mixed States of Manic-Depressive Insanity: a translation and commentary on its significance in the evolution of the concept of bipolar disorder.
Harvard review of psychiatry 2002;10(5):255-75.
2002: Zhang Kehong; Davids Eugen; Tarazi Frank I; Baldessarini Ross J
Serotonin transporter binding increases in caudate-putamen and nucleus accumbens after neonatal 6-hydroxydopamine lesions in rats: implications for motor hyperactivity.
Brain research. Developmental brain research 2002;137(2):135-8.
2002: Baldessarini Ross J; Ghaemi S Nassir; Viguera Adele C
Tolerance in antidepressant treatment.
Psychotherapy and psychosomatics 2002;71(4):177-9.
2002: Zhu Meng-Yang; Kim Chun-Hyung; Hwang Dong-Youn; Baldessarini Ross J; Kim Kwang-Soo
Effects of desipramine treatment on norepinephrine transporter gene expression in the cultured SK-N-BE(2)M17 cells and rat brain tissue.
Journal of neurochemistry 2002;82(1):146-53.
2002: Viguera Adele C; Cohen Lee S; Baldessarini Ross J; Nonacs Ruta
Managing bipolar disorder during pregnancy: weighing the risks and benefits.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2002;47(5):426-36.
2002: Davids Eugen; Zhang Kehong; Kula Nora S; Tarazi Frank I; Baldessarini Ross J
Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats.
The Journal of pharmacology and experimental therapeutics 2002;301(3):1097-102.
2002: Tarazi Frank I; Zhang Kehong; Baldessarini Ross J
Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions.
Psychopharmacology 2002;161(3):263-70.
2002: Fu Xing; Tan Ping-Zhong; Kula Nora S; Baldessarini Ross; Tamagnan Gilles; Innis Robert B; Baldwin Ronald M
Synthesis, receptor potency, and selectivity of halogenated diphenylpiperidines as serotonin 5-HT2A ligands for PET or SPECT brain imaging.
Journal of medicinal chemistry 2002;45(11):2319-24.
2002: Zhang Kehong; Tarazi Frank I; Davids Eugen; Baldessarini Ross J
Plasticity of dopamine D4 receptors in rat forebrain: temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;26(5):625-33.
2002: Zhang Kehong; Davids Eugen; Tarazi Frank I; Baldessarini Ross J
Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions.
Psychopharmacology 2002;161(1):100-6.
2002: Baldessarini Ross J; Tondo Leonardo; Hennen John; Viguera Adele C
Is lithium still worth using? An update of selected recent research.
Harvard review of psychiatry 2002;10(2):59-75.
2002: Davids Eugen; Zhang Kehong; Tarazi Frank I; Baldessarini Ross J
Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning.
Psychopharmacology 2002;160(1):92-8.
2002: Cesati Richard R; Tamagnan Gilles; Baldwin Ronald M; Zoghbi Sami S; Innis Robert B; Kula Nora S; Baldessarini Ross J; Katzenellenbogen John A
Synthesis of cyclopentadienyltricarbonyl rhenium phenyltropanes by double ligand transfer: organometallic ligands for the dopamine transporter.
Bioconjugate chemistry 2002;13(1):29-39.
2002: Centorrino Franca; Price Bruce H; Tuttle Margaret; Bahk Won-Myong; Hennen John; Albert Matthew J; Baldessarini Ross J
EEG abnormalities during treatment with typical and atypical antipsychotics.
The American journal of psychiatry 2002;159(1):109-15.
2002: Baldessarini Ross J
Treatment research in bipolar disorder: issues and recommendations.
CNS drugs 2002;16(11):721-9.
2002: Kelleher James P; Centorrino Franca; Albert Matthew J; Baldessarini Ross J
Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents.
CNS drugs 2002;16(4):249-61.
2002: Tarsy Daniel; Baldessarini Ross J; Tarazi Frank I
Effects of newer antipsychotics on extrapyramidal function.
CNS drugs 2002;16(1):23-45.
2001: Gu X H; Zong R; Kula N S; Baldessarini R J; Neumeyer J L
Synthesis and biological evaluation of a series of novel N- or O-fluoroalkyl derivatives of tropane: potential positron emission tomography (PET) imaging agents for the dopamine transporter.
Bioorganic & medicinal chemistry letters 2001;11(23):3049-53.
2001: Zhang K; Tarazi F I; Baldessarini R J
Role of dopamine D(4) receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;25(5):624-32.
2001: Viguera A C; Baldessarini R J; Tondo L
Response to lithium maintenance treatment in bipolar disorders: comparison of women and men.
Bipolar disorders 2001;3(5):245-52.
2001: Tondo L; Hennen J; Baldessarini R J
Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis.
Acta psychiatrica Scandinavica 2001;104(3):163-72.
2001: Ghaemi S N; Lenox M S; Baldessarini R J
Effectiveness and safety of long-term antidepressant treatment in bipolar disorder.
The Journal of clinical psychiatry 2001;62(7):565-9.
2001: Tondo L; Baldessarini R J; Floris G
Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders.
The British journal of psychiatry. Supplement 2001;41():s184-90.
2001: Zhang K; Tarazi F I; Baldessarini R J
Nigrostriatal dopaminergic denervation enhances dopamine D(4) receptor binding in rat caudate-putamen.
Pharmacology, biochemistry, and behavior 2001;69(1-2):111-6.
2001: Tarazi F I; Zhang K; Baldessarini R J
Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment.
The Journal of pharmacology and experimental therapeutics 2001;297(2):711-7.
2001: Baldessarini R J; Tondo L; Hennen J
Treating the suicidal patient with bipolar disorder. Reducing suicide risk with lithium.
Annals of the New York Academy of Sciences 2001;932():24-38; discussion 39-43.
2001: Centorrino F; Hernán M A; Drago-Ferrante G; Rendall M; Apicella A; Längar G; Baldessarini R J
Factors associated with noncompliance with psychiatric outpatient visits.
Psychiatric services (Washington, D.C.) 2001;52(3):378-80.
2001: Baldessarini R J; Campbell A; Webb N L; Swindell C S; Flood J G; Shashoua V E; Kula N S; Hemamalini S; Bradley M O
Fatty acid derivatives of clozapine: prolonged antidopaminergic activity of docosahexaenoylclozapine in the rat.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;24(1):55-65.
2000: Baldessarini R J; Tondo L; Floris G; Hennen J
Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients.
Journal of affective disorders 2000;61(1-2):13-22.
2000: Tarazi F I; Zhang K; Baldessarini R J
Effects of nigrostriatal dopamine denervation on ionotropic glutamate receptors in rat caudate-putamen.
Brain research 2000;881(1):69-72.
2000: Tohen M; Strakowski S M; Zarate C; Hennen J; Stoll A L; Suppes T; Faedda G L; Cohen B M; Gebre-Medhin P; Baldessarini R J
The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis.
Biological psychiatry 2000;48(6):467-76.
2000: Huxley N A; Parikh S V; Baldessarini R J
Effectiveness of psychosocial treatments in bipolar disorder: state of the evidence.
Harvard review of psychiatry 2000;8(3):126-40.
2000: Viguera A C; Tondo L; Baldessarini R J
Sex differences in response to lithium treatment.
The American journal of psychiatry 2000;157(9):1509-11.
2000: Tamagnan G; Baldwin R M; Kula N S; Baldessarini R J; Innis R B
Synthesis and monoamine transporter affinity of 2beta-carbomethoxy-3beta-(2''-, 3''- or 4''-substituted) biphenyltropanes.
Bioorganic & medicinal chemistry letters 2000;10(16):1783-5.
2000: Tarazi F I; Kula N S; Zhang K; Baldessarini R J
Alkylation of rat dopamine transporters and blockade of dopamine uptake by EEDQ.
Neuropharmacology 2000;39(11):2133-8.
2000: Tarazi F I; Zhang K; Baldessarini R J
Olanzapine, quetiapine, and risperidone: long-term effects on monoamine transporters in rat forebrain.
Neuroscience letters 2000;287(2):81-4.
2000: Tamagnan G; Baldwin R M; Kula N S; Baldessarini R J; Innis R B
Cyclopentadienyltricarbonylrheniumbenzazepines: synthesis and binding affinity.
Bioorganic & medicinal chemistry letters 2000;10(10):1113-5.
2000: Baldessarini R J; Tohen M; Tondo L
Maintenance treatment in bipolar disorder.
Archives of general psychiatry 2000;57(5):490-2.
2000: Baldessarini R J
A plea for integrity of the bipolar disorder concept.
Bipolar disorders 2000;2(1):3-7.
2000: Tarazi F I; Baldessarini R J
Comparative postnatal development of dopamine D(1), D(2) and D(4) receptors in rat forebrain.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 2000;18(1):29-37.
2000: Tohen M; Hennen J; Zarate C M; Baldessarini R J; Strakowski S M; Stoll A L; Faedda G L; Suppes T; Gebre-Medhin P; Cohen B M
Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features.
The American journal of psychiatry 2000;157(2):220-8.
2000: Viguera A C; Nonacs R; Cohen L S; Tondo L; Murray A; Baldessarini R J
Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance.
The American journal of psychiatry 2000;157(2):179-84.
2000: Baldessarini R J; Tondo L
Does lithium treatment still work? Evidence of stable responses over three decades.
Archives of general psychiatry 2000;57(2):187-90.
2000: Zhang K; Tarazi F I; Campbell A; Baldessarini R J
GABA(B) receptors: altered coupling to G-proteins in rats sensitized to amphetamine.
Neuroscience 2000;101(1):5-10.
2000: Tondo L; Baldessarini R J
Reduced suicide risk during lithium maintenance treatment.
The Journal of clinical psychiatry 2000;61 Suppl 9():97-104.
2000: Zhang K; Tarazi F I; Baldessarini R J
Dopamine D(4) receptors in rat forebrain: unchanged with amphetamine-induced behavioral sensitization.
Neuroscience 2000;97(2):211-3.
1999: Baldessarini R J; Tondo L; Hennen J; Floris G
Latency and episodes before treatment: response to lithium maintenance in bipolar I and II disorders.
Bipolar disorders 1999;1(2):91-7.
1999: Tarazi F I; Baldessarini R J
Dopamine D4 receptors: significance for molecular psychiatry at the millennium.
Molecular psychiatry 1999;4(6):529-38.
1999: Zhang K; Weiss N T; Tarazi F I; Kula N S; Baldessarini R J
Effects of alkylating agents on dopamine D(3) receptors in rat brain: selective protection by dopamine.
Brain research 1999;847(1):32-7.
1999: Baldessarini R J; Tondo L; Viguera A C
Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications.
Bipolar disorders 1999;1(1):17-24.
1999: Baldessarini R J; Tondo L; Hennen J
Treatment delays in bipolar disorders.
The American journal of psychiatry 1999;156(5):811-2.
1999: Tarazi F I; Baldessarini R J
Regional localization of dopamine and ionotropic glutamate receptor subtypes in striatolimbic brain regions.
Journal of neuroscience research 1999;55(4):401-10.
1999: Kula N S; Tarazi F I; Baldessarini R J; Xu L; Bakthavachalam V; Pounds S; True C D
Neuropharmacological assessment of potential dopamine D4 receptor-selective radioligands.
European journal of pharmacology 1999;367(1):139-42.
1999: Tarazi F I; Tomasini E C; Baldessarini R J
Postnatal development of dopamine D1-like receptors in rat cortical and striatolimbic brain regions: An autoradiographic study.
Developmental neuroscience 1999;21(1):43-9.
1999: Baldessarini R J; Jamison K R
Effects of medical interventions on suicidal behavior. Summary and conclusions.
The Journal of clinical psychiatry 1999;60 Suppl 2():117-22.
1999: Baldessarini R J; Tondo L; Hennen J
Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders.
The Journal of clinical psychiatry 1999;60 Suppl 2():77-84; discussion 111-6.
1999: Tondo L; Baldessarini R J; Hennen J; Minnai G P; Salis P; Scamonatti L; Masia M; Ghiani C; Mannu P
Suicide attempts in major affective disorder patients with comorbid substance use disorders.
The Journal of clinical psychiatry 1999;60 Suppl 2():63-9; discussion 75-6, 113-6.
1998: Tarazi F I; Campbell A; Baldessarini R J
Effects of hippocampal kainic acid lesions on striatolimbic dopamine D1-, D2-, and D4-like receptors.
Neuroscience 1998;87(1):1-4.
1998: Tondo L; Baldessarini R J
Rapid cycling in women and men with bipolar manic-depressive disorders.
The American journal of psychiatry 1998;155(10):1434-6.
1998: Tarazi F I; Tomasini E C; Baldessarini R J
Postnatal development of dopamine D4-like receptors in rat forebrain regions: comparison with D2-like receptors.
Brain research. Developmental brain research 1998;110(2):227-33.
1998: Tarazi F I; Campbell A; Yeghiayan S K; Baldessarini R J
Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors.
Synapse (New York, N.Y.) 1998;30(2):227-35.
1998: Tarazi F I; Tomasini E C; Baldessarini R J
Postnatal development of dopamine and serotonin transporters in rat caudate-putamen and nucleus accumbens septi.
Neuroscience letters 1998;254(1):21-4.
1998: Tondo L; Baldessarini R J; Hennen J; Floris G; Silvetti F; Tohen M
Lithium treatment and risk of suicidal behavior in bipolar disorder patients.
The Journal of clinical psychiatry 1998;59(8):405-14.
1998: Tarazi F I; Campbell A; Baldessarini R J
Effects of hippocampal lesions on striatolimbic ionotropic glutamatergic receptors.
Neuroscience letters 1998;250(1):13-6.
1998: Tarazi F I; Yeghiayan S K; Neumeyer J L; Baldessarini R J
Medial prefrontal cortical D2 and striatolimbic D4 dopamine receptors: common targets for typical and atypical antipsychotic drugs.
Progress in neuro-psychopharmacology & biological psychiatry 1998;22(4):693-707.
1998: Teicher M H; Andersen S L; Campbell A; Gelbard H A; Baldessarini R J
Progressive accumbens degeneration after neonatal striatal 6-hydroxydopamine in rats.
Neuroscience letters 1998;247(2-3):99-102.
1998: Yeghiayan S K; Gongwer M A; Baldessarini R J; Kula N S; Zong R; Neumeyer J L
Local injection of alkylating and nonalkylating dopamine receptor antagonists into rat basal forebrain: autoradiographic assessment of D2-like and D3 sites.
Brain research 1998;792(2):324-6.
1998: Tondo L; Baldessarini R J; Hennen J; Floris G
Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders.
The American journal of psychiatry 1998;155(5):638-45.
1998: Viguera A C; Baldessarini R J; Friedberg J
Discontinuing antidepressant treatment in major depression.
Harvard review of psychiatry 1998;5(6):293-306.
1998: Tarazi F I; Campbell A; Yeghiayan S K; Baldessarini R J
Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors.
Neuroscience 1998;83(1):169-76.
1997: Tondo L; Jamison K R; Baldessarini R J
Effect of lithium maintenance on suicidal behavior in major mood disorders.
Annals of the New York Academy of Sciences 1997;836():339-51.
1997: Tarazi F I; Kula N S; Baldessarini R J
Regional distribution of dopamine D4 receptors in rat forebrain.
Neuroreport 1997;8(16):3423-6.
1997: Yeghiayan S K; Andersen S L; Baldessarini R J
Lack of effect of chronic clorgyline or selegiline on dopamine and serotonin transporters in rat caudate-putamen or nucleus accumbens septi.
Neuroscience letters 1997;236(3):147-50.
1997: Campbell A; Villavicencio A T; Yeghiayan S K; Balikian R; Baldessarini R J
Mapping of locomotor behavioral arousal induced by microinjections of dopamine within nucleus accumbens septi of rat forebrain.
Brain research 1997;771(1):55-62.
1997: Tarazi F I; Yeghiayan S K; Baldessarini R J; Kula N S; Neumeyer J L
Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;17(3):186-96.
1997: Kula N S; Baldessarini R J; Kebabian J W; Bakthavachalam V; Xu L
RBI-257: a highly potent dopamine D4 receptor-selective ligand.
European journal of pharmacology 1997;331(2-3):333-6.
1997: Baldessarini R J; Hegarty J D; Bird E D; Benes F M
Meta-analysis of postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia.
The American journal of psychiatry 1997;154(6):861-3.
1997: Bodkin J A; Lasser R A; Wines J D; Gardner D M; Baldessarini R J
Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.
The Journal of clinical psychiatry 1997;58(4):137-45.
1997: Baldessarini R J; Tondo L; Floris G; Rudas N
Reduced morbidity after gradual discontinuation of lithium treatment for bipolar I and II disorders: a replication study.
The American journal of psychiatry 1997;154(4):551-3.
1997: Tondo L; Baldessarini R J; Floris G; Rudas N
Effectiveness of restarting lithium treatment after its discontinuation in bipolar I and bipolar II disorders.
The American journal of psychiatry 1997;154(4):548-50.
1997: Lasser R A; Baldessarini R J
Thyroid hormones in depressive disorders: a reappraisal of clinical utility.
Harvard review of psychiatry 1997;4(6):291-305.
1997: Yeghiayan S K; Kelley A E; Kula N S; Campbell A; Baldessarini R J
Role of dopamine in behavioral effects of serotonin microinjected into rat striatum.
Pharmacology, biochemistry, and behavior 1997;56(2):251-9.
1997: Viguera A C; Baldessarini R J; Hegarty J D; van Kammen D P; Tohen M
Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment.
Archives of general psychiatry 1997;54(1):49-55.
1996: Meyer M C; Baldessarini R J; Goff D C; Centorrino F
Clinically significant interactions of psychotropic agents with antipsychotic drugs.
Drug safety : an international journal of medical toxicology and drug experience 1996;15(5):333-46.
1996: Baldessarini R J; Tondo L; Faedda G L; Suppes T R; Floris G; Rudas N
Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders.
The Journal of clinical psychiatry 1996;57(10):441-8.
1996: Centorrino F; Baldessarini R J; Frankenburg F R; Kando J; Volpicelli S A; Flood J G
Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors.
The American journal of psychiatry 1996;153(6):820-2.
1996: Baldessarini R J; Tarazi F I
Brain dopamine receptors: a primer on their current status, basic and clinical.
Harvard review of psychiatry 1996;3(6):301-25.
1995: Wyrick S D; Booth R G; Myers A M; Owens C E; Bucholtz E C; Hooper P C; Kula N S; Baldessarini R J; Mailman R B
1-Phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes and related derivatives as ligands for the neuromodulatory sigma 3 receptor: further structure-activity relationships.
Journal of medicinal chemistry 1995;38(19):3857-64.
1995: Baldessarini R J; Kando J C; Centorrino F
Hospital use of antipsychotic agents in 1989 and 1993: stable dosing with decreased length of stay.
The American journal of psychiatry 1995;152(7):1038-44.
1995: Centorrino F; Baldessarini R J; Flood J G; Kando J C; Frankenburg F R
Relation of leukocyte counts during clozapine treatment to serum concentrations of clozapine and metabolites.
The American journal of psychiatry 1995;152(4):610-2.
1995: Tohen M; Castillo J; Baldessarini R J; Zarate C; Kando J C
Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk.
The American journal of psychiatry 1995;152(3):413-8.
1994: Myers A M; Charifson P S; Owens C E; Kula N S; McPhail A T; Baldessarini R J; Booth R G; Wyrick S D
Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptor.
Journal of medicinal chemistry 1994;37(24):4109-17.
1994: Hegarty J D; Baldessarini R J; Tohen M; Waternaux C; Oepen G
One hundred years of schizophrenia: a meta-analysis of the outcome literature.
The American journal of psychiatry 1994;151(10):1409-16.
1994: Booth R G; Baldessarini R J; Marsh E; Owens C E
Actions of (+/-)-7-hydroxy-N,N-dipropylaminotetralin (7-OH-DPAT) on dopamine synthesis in limbic and extrapyramidal regions of rat brain.
Brain research 1994;662(1-2):283-8.
1994: Baldessarini R J; Campbell A; Ben-Jonathan N; Ellingboe J; Zong R; Neumeyer J L
Effects of aporphine isomers on rat prolactin.
Neuroscience letters 1994;176(2):269-71.
1994: Baldessarini R J; Marsh E R; Huston-Lyons D
Effects of dopamine partial-agonist aminoergolines on dopamine metabolism in limbic and extrapyramidal regions of rat brain.
Biochemical pharmacology 1994;47(10):1917-9.
1994: Centorrino F; Baldessarini R J; Kando J C; Frankenburg F R; Volpicelli S A; Flood J G
Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patients.
Journal of clinical psychopharmacology 1994;14(2):119-25.
1994: Baldessarini R J; Kula N S; Zong R; Neumeyer J L
Receptor affinities of aporphine enantiomers in rat brain tissue.
European journal of pharmacology 1994;254(1-2):199-203.
1994: Centorrino F; Baldessarini R J; Kando J; Frankenburg F R; Volpicelli S A; Puopolo P R; Flood J G
Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate.
The American journal of psychiatry 1994;151(1):123-5.
1993: Booth R G; Wyrick S D; Baldessarini R J; Kula N S; Myers A M; Mailman R B
New sigma-like receptor recognized by novel phenylaminotetralins: ligand binding and functional studies.
Molecular pharmacology 1993;44(6):1232-9.
1993: Suppes T; Baldessarini R J; Faedda G L; Tondo L; Tohen M
Discontinuation of maintenance treatment in bipolar disorder: risks and implications.
Harvard review of psychiatry 1993;1(3):131-44.
1993: Teicher M H; Barber N I; Gelbard H A; Gallitano A L; Campbell A; Marsh E; Baldessarini R J
Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1993;9(2):147-56.
1993: Baldessarini R J; Centorrino F; Flood J G; Volpicelli S A; Huston-Lyons D; Cohen B M
Tissue concentrations of clozapine and its metabolites in the rat.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1993;9(2):117-24.
1993: Volpicelli S A; Centorrino F; Puopolo P R; Kando J; Frankenburg F R; Baldessarini R J; Flood J G
Determination of clozapine, norclozapine, and clozapine-N-oxide in serum by liquid chromatography.
Clinical chemistry 1993;39(8):1656-9.
1993: Baldessarini R J; Kula N S; McGrath C R; Bakthavachalam V; Kebabian J W; Neumeyer J L
Isomeric selectivity at dopamine D3 receptors.
European journal of pharmacology 1993;239(1-3):269-70.
1993: Wyrick S D; Booth R G; Myers A M; Owens C E; Kula N S; Baldessarini R J; McPhail A T; Mailman R B
Synthesis and pharmacological evaluation of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for a novel receptor with sigma-like neuromodulatory activity.
Journal of medicinal chemistry 1993;36(17):2542-51.
1993: Wilens T E; Biederman J; Baldessarini R J; Puopolo P R; Flood J G
Electrocardiographic effects of desipramine and 2-hydroxydesipramine in children, adolescents, and adults treated with desipramine.
Journal of the American Academy of Child and Adolescent Psychiatry 1993;32(4):798-804.
1993: Faedda G L; Tondo L; Baldessarini R J; Suppes T; Tohen M
Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders.
Archives of general psychiatry 1993;50(6):448-55.
1993: Faedda G L; Tondo L; Teicher M H; Baldessarini R J; Gelbard H A; Floris G F
Seasonal mood disorders. Patterns of seasonal recurrence in mania and depression.
Archives of general psychiatry 1993;50(1):17-23.
1993: Campbell A; Baldessarini R J; Neumeyer J L
Altered spontaneous behavior and sensitivity to apomorphine in rats following pretreatment with S(+)-aporphines or fluphenazine.
Psychopharmacology 1993;111(3):351-8.
1992: Baldessarini R J; Kula N S; Campbell A; Bakthavachalam V; Yuan J; Neumeyer J L
Prolonged D2 antidopaminergic activity of alkylating and nonalkylating derivatives of spiperone in rat brain.
Molecular pharmacology 1992;42(5):856-63.
1992: Campbell A; Baldessarini R J; Yeghiayan S
Antagonism of limbic and extrapyramidal actions of intracerebrally injected dopamine by ergolines with partial D2 agonist activity in the rat.
Brain research 1992;592(1-2):348-52.
1992: Wilens T E; Biederman J; Baldessarini R J; McDermott S P; Puopolo P R; Flood J G
Fluoxetine inhibits desipramine metabolism.
Archives of general psychiatry 1992;49(9):752.
1992: Wilens T E; Biederman J; Baldessarini R J; Puopolo P R; Flood J G
Developmental changes in serum concentrations of desipramine and 2-hydroxydesipramine during treatment with desipramine.
Journal of the American Academy of Child and Adolescent Psychiatry 1992;31(4):691-8.
1992: Baldessarini R J; Marsh E R; Kula N S
Interactions of fluoxetine with metabolism of dopamine and serotonin in rat brain regions.
Brain research 1992;579(1):152-6.
1992: Baldessarini R J; Huston-Lyons D; Campbell A; Marsh E; Cohen B M
Do central antiadrenergic actions contribute to the atypical properties of clozapine?
The British journal of psychiatry. Supplement 1992;(17):12-6.
1992: Kula N S; George T; Baldessarini R J
Rate of recovery of D1 and D2 dopaminergic receptors in young vs. adult rat striatal tissue following alkylation with ethoxycarbonyl-ethoxy-dihydroquinoline (EEDQ).
Brain research. Developmental brain research 1992;66(2):286-9.
1992: Neumeyer J L; Kula N S; Baldessarini R J; Baindur N
Stereoisomeric probes for the D1 dopamine receptor: synthesis and characterization of R-(+) and S-(-) enantiomers of 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its 6-bromo analogue.
Journal of medicinal chemistry 1992;35(8):1466-71.
1992: Neumeyer J L; Baindur N; Bakthavachalam V; Yuan J; Madras B K; Kula N S; Campbell A; Baldessarini R J
Alan Horn Memorial Lecture. Selective probes for characterization of dopamine D1 and D2 receptors.
Neurochemistry international 1992;20 Suppl():63S-68S.
1991: Suppes T; Baldessarini R J; Faedda G L; Tohen M
Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.
Archives of general psychiatry 1991;48(12):1082-8.
1991: Teicher M H; Gallitano A L; Gelbard H A; Evans H K; Marsh E R; Booth R G; Baldessarini R J
Dopamine D1 autoreceptor function: possible expression in developing rat prefrontal cortex and striatum.
Brain research. Developmental brain research 1991;63(1-2):229-35.
1991: Satlin A; Teicher M H; Lieberman H R; Baldessarini R J; Volicer L; Rheaume Y
Circadian locomotor activity rhythms in Alzheimer's disease.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1991;5(2):115-26.
1991: Faedda G L; Baldessarini R J; Tohen M; Strakowski S M; Waternaux C
Episode sequence in bipolar disorder and response to lithium treatment.
The American journal of psychiatry 1991;148(9):1237-9.
1991: Booth R G; Baldessarini R J
(+)-6,7-benzomorphan sigma ligands stimulate dopamine synthesis in rat corpus striatum tissue.
Brain research 1991;557(1-2):349-52.
1991: Booth R G; Baldessarini R J; Campbell A
Inhibition of dopamine synthesis in rat striatal minces: evidence of dopamine autoreceptor supersensitivity to S(+)- but not R(-)-N-n-propylnorapomorphine after pretreatment with fluphenazine.
Biochemical pharmacology 1991;41(12):2040-3.
1991: Baldessarini R J; Frankenburg F R
Clozapine. A novel antipsychotic agent.
The New England journal of medicine 1991;324(11):746-54.
1991: Kula N S; Baldessarini R J
Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine.
Neuropharmacology 1991;30(1):89-92.
1991: Baldessarini R J; Kula N S; Gao Y; Campbell A; Neumeyer J L
R(-)2-fluoro-N-n-propylnorapomorphine: a very potent and D2-selective dopamine agonist.
Neuropharmacology 1991;30(1):97-9.
1991: Neumeyer J L; Gao Y G; Kula N S; Baldessarini R J
R and S enantiomers of 11-hydroxy- and 10,11-dihydroxy-N-allylnoraporphine: synthesis and affinity for dopamine receptors in rat brain tissue.
Journal of medicinal chemistry 1991;34(1):24-8.
1991: Campbell A; Yeghiayan S; Baldessarini R J; Neumeyer J L
Selective antidopaminergic effects of S(+)N-n-propylnoraporphines in limbic versus extrapyramidal sites in rat brain: comparisons with typical and atypical antipsychotic agents.
Psychopharmacology 1991;103(3):323-9.
1990: Neumeyer J L; Gao Y G; Kula N S; Baldessarini R J
Synthesis and dopamine receptor affinity of (R)-(-)-2-fluoro-N-n-propylnorapomorphine: a highly potent and selective dopamine D2 agonist.
Journal of medicinal chemistry 1990;33(12):3122-4.
1990: Gelbard H A; Teicher M H; Baldessarini R J; Gallitano A; Marsh E R; Zorc J; Faedda G
Dopamine D1 receptor development depends on endogenous dopamine.
Brain research. Developmental brain research 1990;56(1):137-40.
1990: Baldessarini R J; Marsh E R; Kula N S; Zong R S; Gao Y G; Neumeyer J L
Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions.
Biochemical pharmacology 1990;40(3):417-23.
1990: Booth R G; Baldessarini R J
Adenosine A2 stimulation of tyrosine hydroxylase in rat striatal minces is reversed by dopamine D2 autoreceptor activation.
European journal of pharmacology 1990;185(2-3):217-21.
1990: Booth R G; Baldessarini R J; Kula N S; Gao Y; Zong R; Neumeyer J L
Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
Molecular pharmacology 1990;38(1):92-101.
1990: Campbell A; Baldessarini R J; Gao Y; Zong R; Neumeyer J L
R(-) and S(+) stereoisomers of 11-hydroxy- and 11-methoxy-N-n-propylnoraporphine: central dopaminergic behavioral activity in the rat.
Neuropharmacology 1990;29(6):527-36.
1990: Gao Y G; Baldessarini R J; Kula N S; Neumeyer J L
Synthesis and dopamine receptor affinities of enantiomers of 2-substituted apomorphines and their N-n-propyl analogues.
Journal of medicinal chemistry 1990;33(6):1800-5.
1990: Gao Y G; Ram V J; Campbell A; Kula N S; Baldessarini R J; Neumeyer J L
Synthesis and structural requirements of N-substituted norapomorphines for affinity and activity at dopamine D-1, D-2, and agonist receptor sites in rat brain.
Journal of medicinal chemistry 1990;33(1):39-44.
1989: Campbell A; Baldessarini R J; Cremens C; Teicher M H; Marsh E; Kula N S
Bromocriptine antagonizes behavioral effects of cocaine in the rat.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1989;2(3):209-24.
1989: Gelbard H A; Teicher M H; Faedda G; Baldessarini R J
Postnatal development of dopamine D1 and D2 receptor sites in rat striatum.
Brain research. Developmental brain research 1989;49(1):123-30.
1989: Baldessarini R J
Current status of antidepressants: clinical pharmacology and therapy.
The Journal of clinical psychiatry 1989;50(4):117-26.
1989: Faedda G; Kula N S; Baldessarini R J
Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
Biochemical pharmacology 1989;38(3):473-80.
1989: Barber N I; Teicher M H; Baldessarini R J
Effects of selective monoaminergic reuptake blockade on activity rhythms in developing rats.
Psychopharmacology 1989;97(3):343-8.
1988: Teicher M H; Cohen B M; Baldessarini R J; Cole J O
Severe daytime somnolence in patients treated with an MAOI.
The American journal of psychiatry 1988;145(12):1552-6.
1988: Trainor T M; Vouros P; Lampen P; Neumeyer J L; Baldessarini R J; Kula N S
Determination of N-n-propylnorapomorphine in serum and brain tissue by gas chromatography-negative ion chemical ionization mass spectrometry.
Journal of chromatography 1988;457():257-66.
1988: Campbell A; Baldessarini R J; Cremens M C
Dose-catalepsy response to haloperidol in rat: effects of strain and sex.
Neuropharmacology 1988;27(11):1197-9.
1988: Teicher M H; Lawrence J M; Barber N I; Finklestein S P; Lieberman H R; Baldessarini R J
Increased activity and phase delay in circadian motility rhythms in geriatric depression. Preliminary observations.
Archives of general psychiatry 1988;45(10):913-7.
1988: Gao Y; Zong R; Campbell A; Kula N S; Baldessarini R J; Neumeyer J L
Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
Journal of medicinal chemistry 1988;31(7):1392-6.
1988: Baldessarini R J; Vogt M
Release of 3H-dopamine and analogous monoamines from rat striatal tissue.
Cellular and molecular neurobiology 1988;8(2):205-16.
1988: Lampen P; Neumeyer J L; Baldessarini R J
High-performance liquid chromatographic separation and electrochemical or spectrophotometric determination of R(-)N-n-propylnorapomorphine and R(-)10,11-methylenedioxy-N-n-propylnoraporphine in primate plasma.
Journal of chromatography 1988;426(2):283-94.
1988: Teicher M H; Barber N I; Baldessarini R J; Shaywitz B A
Amphetamine accelerates and attenuates ultradian activity rhythms in preweanling rats.
Pharmacology, biochemistry, and behavior 1988;29(3):517-23.
1988: Kula N S; Baldessarini R J; Murphy F; Neumeyer J L
Substituted phenylpiperidines and phenylpyridines as reversible selective inhibitors of monoamine oxidase type A in rodent brain and liver.
Biochemical pharmacology 1988;37(4):763-6.
1988: Baldessarini R J; Cohen B M; Teicher M H
Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses.
Archives of general psychiatry 1988;45(1):79-91.
1988: Neumeyer J L; Froimowitz M; Baldessarini R J; Campbell A; Gao Y G
Neuropharmacology and stereochemistry of dopamine receptor agonist and antagonist enantiomeric pairs.
Journal of receptor research 1988;8(1-4):83-96.
1988: Campbell A; Baldessarini R J; Teicher M H
Decreasing sensitivity to neuroleptic agents in developing rats; evidence for a pharmacodynamic factor.
Psychopharmacology 1988;94(1):46-51.
1987: Campbell A; Baldessarini R J; Kula N S; Ram V J; Neumeyer J L
S(+)methylenedioxy-N-n-propylnoraporphine: an orally active inhibitor of dopamine selective for rat limbic system.
Brain research 1987;403(2):393-7.
1984: Kula N S; Baldessarini R J; Campbell A; Finklestein S; Ram V J; Neumeyer J L
Effects of N-substituted phenyltetrahydropyridines on cerebral high-affinity synaptosomal uptake of dopamine and other monoamines in several mammalian species.
Life sciences 1984;34(26):2567-75.
1982: Neumeyer J L; Arana G W; Ram V J; Kula N S; Baldessarini R J
Aporphines. 39. Synthesis, dopamine receptor binding, and pharmacological activity of (R)-(-)- and (S)-(+)-2-hydroxyapomorphine.
Journal of medicinal chemistry 1982;25(8):990-2.
1982: Baldessarini R J; Neumeyer J L; Campbell A; Sperk G; Ram V J; Arana G W; Kula N S
An orally effective, long-acting dopaminergic prodrug: (-)-10,11-methylenedioxy-N-propylnoraporphine.
European journal of pharmacology 1982;77(1):87-8.

Sign-in to see more